<DOC>
	<DOCNO>NCT02364908</DOCNO>
	<brief_summary>This study biomedical , open label , therapeutic strategy , interventional , non-randomized , multicenter study evaluate non compliance antimalarial patient systemic lupus Nord Pas-de-Calais region ( FRANCE ) . It conduct two visit . These visit consist obtain blood sample , perform clinical examination fill questionnaire ( Quality Of Life , Coping ... ) . The goal noncompliant patient guide towards therapeutic education professional ( nurse physician ) .</brief_summary>
	<brief_title>Prospective Evaluation Decision Compliance With Antimalarials Patients With Systemic Lupus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>patient systemic lupus ACR criterion ( least 4 criterias ) patient antimalarial least 3 month minimum dose 200 mg/day . patient refuse sign inform consent patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>systemic lupus erythematosus</keyword>
	<keyword>antimalarial</keyword>
	<keyword>therapeutic education</keyword>
	<keyword>Coping questionnaire</keyword>
	<keyword>MASRI questionnaire</keyword>
	<keyword>morisky medication adherence scale</keyword>
	<keyword>lupus Quality Of Life</keyword>
	<keyword>internal medicine</keyword>
</DOC>